Brazil Diabetes Drugs Top Companies AstraZeneca MSD Boehringer Ingelheim Novo Nordisk A/S Sanofi Aventis.
ONGLYZA, an investigational drug under joint development by Bristol-Myers Squibb and AstraZeneca for the treatment of type 2 diabetes, was
FARXIGA is not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic Distributed by: AstraZeneca Pharmaceuticals LP
AstraZeneca enters the hottest part of the pharmaceutical market through an agreement to market obesity and diabetes drugs AstraZeneca (AZN)
The other drugs that received negotiated prices are Merck's diabetes drug Januvia, Novo Nordisk's diabetes drug Fiasp and NovoLog, AstraZeneca's
AstraZeneca Will Negotiate With Medicare On Price For Diabetes Drug Drugmaker AstraZeneca tells Politico that it plans to participate in
British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating
Diabetes, Type 2, Heart Failure, Chronic Kidney Disease. Supplied by AstraZeneca. Drug Application for the treatment of type 2 diabetes
AstraZeneca combo diabetes drug Qtrilmet approved in Europe.
Comments